ULBI - Ultralife Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5144.7M
Enterprise Value 3138.9M
Trailing P/E 6.22
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)1.62
Price/Book (mrq)1.36
Enterprise Value/Revenue 31.55
Enterprise Value/EBITDA 616.29

Trading Information

Stock Price History

Beta (3Y Monthly) 1.52
52-Week Change 34.49%
S&P500 52-Week Change 32.99%
52 Week High 311.97
52 Week Low 36.30
50-Day Moving Average 38.60
200-Day Moving Average 38.97

Share Statistics

Avg Vol (3 month) 326.33k
Avg Vol (10 day) 332.64k
Shares Outstanding 515.76M
Float 9.82M
% Held by Insiders 13.86%
% Held by Institutions 179.53%
Shares Short (Aug 15, 2019) 479.38k
Short Ratio (Aug 15, 2019) 43.17
Short % of Float (Aug 15, 2019) 40.81%
Short % of Shares Outstanding (Aug 15, 2019) 40.50%
Shares Short (prior month Jul 15, 2019) 485.24k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin 26.62%
Operating Margin (ttm)6.88%

Management Effectiveness

Return on Assets (ttm)3.20%
Return on Equity (ttm)25.17%

Income Statement

Revenue (ttm)89.54M
Revenue Per Share (ttm)5.65
Quarterly Revenue Growth (yoy)28.60%
Gross Profit (ttm)25.58M
Net Income Avi to Common (ttm)23.83M
Diluted EPS (ttm)1.48
Quarterly Earnings Growth (yoy)38.70%

Balance Sheet

Total Cash (mrq)6.82M
Total Cash Per Share (mrq)0.43
Total Debt (mrq)16.5M
Total Debt/Equity (mrq)15.56
Current Ratio (mrq)3.38
Book Value Per Share (mrq)6.73

Cash Flow Statement

Operating Cash Flow (ttm)4.82M
Levered Free Cash Flow (ttm)-10.7M